Scroll for more

video

video

Jackie Hunter speaking at The House of Lords

Professor Jackie Hunter, CEO, BenevolentBio, gave evidence at The House of Lords Science and Technology Select Committee

video

Ken Mulvany talks to CNBC at Goldman Sachs’ Disruptive Technology Symposium

Listen to our founder Ken Mulvany discussing BenevolentAI's work on artificial intelligence applied to drug discovery.

video

BenevolentAI – Accelerating Scientific Discovery With AI

BenevolentAI team explains why the use of DGX-1 will help them in their daily work